Financials
Financial year 2025
Ebacin from Merelbeke-Melle, company number BE0795917662, closed financial year 2025 with a result of € 330,474 after tax. For that financial year Ebacin recorded a gross margin of € 21,314 and equity of € 398,037. Compared with financial year 2024, the result moved from € 464,522 to € 330,474. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 9, 2026.
€ 398,037
▲ 49% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 330,474
▼ 29% vs 2024
Profit after tax over the fiscal year.
€ 8,715
▼ 61% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 200,000 paid out
61 % of the profit went to the shareholders, mostly to Destracon (100 % of the shares). That is where the money ends up.
Debts at end 2025
€ 200,000
▼ 33% vs 2024
€ 100,000 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 3,407
▲ 295% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 7,404
▲ 26% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 39,209 | € 38,679 | € 21,314 | ▼ 45% |
| Profit after taxes | € 3,040 | € 464,522 | € 330,474 | ▼ 29% |
| Equity | € 103,040 | € 267,562 | € 398,037 | ▲ 49% |
| Total debts | € 448,236 | € 606,717 | € 210,811 | ▼ 65% |
| Cash | € 27,125 | € 22,566 | € 8,715 | ▼ 61% |
| Retained profit | € 3,040 | € 167,562 | € 298,037 | ▲ 78% |
| Dividend | € 0 | € 300,000 | € 200,000 | ▼ 33% |
| Bank debt | € 445,000 | € 300,000 | € 200,000 | ▼ 33% |
| Balance sheet total | € 551,276 | € 874,279 | € 608,848 | ▼ 30% |
Key figures of Ebacin, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Ebacin?
What happened at Ebacin in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- KLACKEN BV stepped down as director. NBB
- DESTRACON BV stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 330,474 (▼ 29% vs 2024). Source: NBB ↗
- Start of the company according to the CBE. KBO
- KLACKEN BV became a director. NBB
- DESTRACON BV became a director. NBB
In short
From € 3,040 profit in 2023 to € 330,474 profit in 2025.
Paid € 7,679 in corporate taxes since 2023.
Best year ever: 2024, with € 464,522 profit.
Paid out € 500,000 in dividends to the owners in total.
A new publication or filing at Ebacin? We notify you, reason included.
Follow EbacinDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Destracon, KLACKEN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
EbacinThe shares are held by Destracon (100%) and KLACKEN. It owns 100% of Bienca itself.
Directors
According to the 2025 annual accounts
Chairman of the board · represented by Grawet Lieve
since 2023 · until 2029
Director · represented by Brackman Rudolphe
Also active at: BIOTECHNOLOGICAL ENZYMATIC CATALYSE
since 2023 · until 2029
Participations
100%
Establishments
Establishment units
Physical locations of this company
Industriepark 13
9820 Merelbeke-Melle
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0795.917.662
- VAT number
- BE 0795.917.662
- Registered office
- Industriepark 13, 9820 Merelbeke-Melle
- Names & denominations
- Ebacin
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 9 January 2023
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Activiteiten van holdings
Holdings